![]() |
市場調查報告書
商品編碼
1965387
白色生技市場-全球產業規模、佔有率、趨勢、機會、預測:按產品、應用、地區和競爭對手分類,2021-2031年White Biotechnology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region & Competition, 2021-2031F |
||||||
全球白色生物技術市場預計將從 2025 年的 2,625.4 億美元成長到 2031 年的 4,498.4 億美元,複合年成長率為 9.39%。
在這個領域,生物系統(例如酵素和微生物)被用於生產從化學品和材料到生質燃料等各種生物基產品。推動該市場發展的關鍵因素包括對永續工業實踐日益成長的需求,以及旨在減少對石化燃料依賴的嚴格環境法規。例如,歐洲生質塑膠協會報告稱,到2024年,全球生質塑膠產能將達到約247萬噸,這反映了該產業的規模。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 2625.4億美元 |
| 市場規模:2031年 | 4498.4億美元 |
| 複合年成長率:2026-2031年 | 9.39% |
| 成長最快的細分市場 | 生質燃料 |
| 最大的市場 | 北美洲 |
白色生物技術領域廣泛發展的一大障礙是其生產成本高於傳統石油化學製程。這種經濟差距阻礙了尋求更環保技術的企業進入市場,並常常限制了生物基解決方案在價格敏感型市場的擴充性應用。因此,與成熟方法相比,經濟劣勢仍然是其廣泛應用的一大挑戰。
政府對可再生化學品生產的獎勵和補貼是推動白色生物技術市場發展的主要動力,因為它能降低生物基基礎設施擴張帶來的財務風險。諸如津貼和貸款擔保之類的機制對於應對高昂的資本成本往往阻礙實驗室研究向商業化生產過渡的挑戰至關重要。透過降低投資風險,世界各國政府正加速加強國內生物經濟供應鏈,並推動經濟多元化,擺脫對石化產品的依賴。例如,2024年10月,BioMADE在一份題為「BioMADE投資2,690萬美元用於17個計劃」的新聞稿中宣布,已撥款支持國內生物產業製造創新規模化發展。這將使企業能夠建造試點設施並最佳化發酵製程。
同時,合成生物學和酵素工程的進步正在透過提高微生物細胞工廠的效率和產量來改變市場模式。人工智慧驅動的最佳化和精準的基因重編程使研究人員能夠設計出將原料轉化為高價值化學品的微生物,其轉化率極高,且具有顯著的特異性,與傳統萃取方法相比,單位成本顯著降低。這項技術的成熟正在推動其在從家居用品到農業等各行業的快速商業性化應用。例如,Novonesys公司在2025年2月發布的「公司公告3」中報告稱,其2024年的有機銷售額成長了8%,證實了工業領域的強勁需求成長。此外,白宮在2024年指出,自該舉措啟動以來,聯邦政策已推動公共和私人生物製造領域的投資總額達到460億美元。
與成熟的石油化學方法相比,更高的生產成本是白色生物技術市場面臨的主要結構性障礙。生物基生產流程需要對先進的發酵技術、純化系統和專用原料供應鏈進行大量資本投資,所有這些都會增加營運成本。與受益於數十年最佳化基礎設施和大規模經濟規模的石油化學產業不同,白色生物技術公司往往面臨高昂的單位成本,這降低了最終產品在全球價格敏感型市場中的競爭力。
這種經濟差距直接限制了生物基解決方案的擴充性,尤其是在利潤率較低的領域,例如工業材料和通用化學品。當價格溢價威脅到盈利時,製造商往往會猶豫是否要全面轉型為環保替代品,導致市場滲透速度放緩。根據世界生質能源協會預測,到2024年,全球乙醇產量將達到1,180億公升。雖然這無疑是一個龐大的數字,但持續存在的成本限制表明,要實現完全替代現有石化燃料衍生產品所需的巨大產量仍然充滿挑戰。
酵素法解決方案在塑膠回收再利用和增值回收的興起,標誌著白色生物技術市場的一個重要轉折點,它克服了機械方面的限制,實現了材料的無限循環利用。先進的酵素法製程能夠將PET和尼龍等複雜塑膠分解成原生級單體,這些單體可以重新投入生產循環,且性能不會劣化。這項技術滿足了業界對高品質再生材料的關鍵需求,同時減少了環境污染。為了體現這項技術的商業性勢頭,Samsara Eco在2024年6月發布的新聞稿《Samsara Eco完成A+輪融資1億美元,致力於終結塑膠廢棄物》中宣布,已籌集約6500萬美元,用於加速酶法回收技術的部署,並在東南亞建設新的生產設施。
同時,市場正轉向非食品生質能和廢棄物衍生原料,這使得化學品生產與食品供應鏈脫鉤。製造商擴大使用農業殘餘物和工業廢氣作為主要原料,從而減少碳足跡並降低與經濟作物相關的價格波動風險。這種轉變得益於氣體發酵技術,該技術可以將碳排放轉化為有價值的中間體,例如永續燃料和乙醇。以LanzaTec為例,該公司在2024年8月發布的2024年第二季財報中報告稱,其收入成長了35%,達到1740萬美元,這主要得益於其碳回收和生物煉製業務的擴張,這體現了廢棄物變廢為寶工藝日益成長的經濟可行性。
The Global White Biotechnology Market is projected to expand from USD 262.54 Billion in 2025 to USD 449.84 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.39%. This sector involves utilizing biological systems, such as enzymes and microorganisms, to produce biobased goods ranging from chemicals and materials to biofuels. Key factors driving this market include the rising demand for sustainable industrial practices and stringent environmental regulations designed to decrease dependence on fossil fuels. Highlighting the scale of the industry, European Bioplastics reported that global bioplastics production capacity reached approximately 2.47 million tonnes in 2024.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 262.54 Billion |
| Market Size 2031 | USD 449.84 Billion |
| CAGR 2026-2031 | 9.39% |
| Fastest Growing Segment | Biofuels |
| Largest Market | North America |
A significant obstacle hindering the broader growth of the white biotechnology sector is the elevated production cost relative to conventional petrochemical processes. This financial discrepancy often creates a barrier to entry for businesses attempting to adopt greener technologies and restricts the scalability of biobased solutions in price-sensitive markets. Consequently, the economic disadvantage compared to established methods remains a critical challenge for widespread adoption.
Market Driver
Government incentives and subsidies for renewable chemical production serve as a major catalyst for the white biotechnology market by alleviating the financial risks associated with expanding bio-based infrastructure. Mechanisms such as grants and loan guarantees are crucial for bridging the gap between laboratory research and commercial-scale manufacturing, a stage where high capital costs often impede progress. By de-risking these investments, governments are strengthening domestic bioeconomy supply chains and accelerating the shift away from petrochemical reliance. For instance, BioMADE announced in October 2024, in a press release titled 'BioMADE Announces $26.9 Million Invested in 17 Projects', that it allocated funds to support the scaling of domestic bioindustrial manufacturing innovations, enabling companies to build pilot facilities and optimize fermentation processes.
Simultaneously, advancements in synthetic biology and enzyme engineering are transforming the market by improving the efficiency and yield of microbial cell factories. Through AI-driven optimization and precise genetic reprogramming, researchers can design microorganisms to convert feedstocks into high-value chemicals with remarkable specificity, significantly reducing unit costs compared to traditional extraction methods. This technological maturation is driving rapid commercial adoption across various industries, from household care to agriculture. Highlighting this momentum, Novonesis reported in its February 2025 'Company Announcement no. 3' an 8% organic sales growth for 2024, underscoring strong industrial uptake. Furthermore, the White House noted in 2024 that federal policies have spurred a total of $46 billion in public and private biomanufacturing investments since the initiative began.
Market Challenge
The high cost of production relative to established petrochemical methods constitutes a major structural barrier for the white biotechnology market. Bio-based manufacturing processes generally require substantial capital for advanced fermentation technologies, purification systems, and specialized feedstock supply chains, all of which increase operational expenses. Unlike the petrochemical industry, which benefits from decades of optimized infrastructure and large economies of scale, white biotechnology firms often face higher unit costs that make their end products less competitive in price-sensitive global markets.
This economic disparity directly limits the scalability of biobased solutions, particularly in sectors with thin profit margins like industrial materials and commodity chemicals. Manufacturers are often hesitant to fully transition to greener alternatives when price premiums threaten profitability, effectively slowing the rate of market penetration. According to the World Bioenergy Association, global ethanol output reached 118 billion liters in 2024, a figure that, while significant, emphasizes the continued difficulty in achieving the massive volumes required to fully displace fossil-based incumbents due to these persistent cost constraints.
Market Trends
The rise of enzymatic solutions for plastic recycling and upcycling marks a pivotal shift in the white biotechnology market, overcoming mechanical limitations to enable infinite material circularity. Advanced enzymatic processes break down complex plastics such as PET and nylon into their virgin-grade monomers, permitting their reintroduction into manufacturing cycles without performance degradation. This capability meets the critical industry need for high-quality recycled content while reducing environmental pollution. Reflecting the commercial momentum of this technology, Samsara Eco announced in June 2024, in the release 'Samsara Eco secures $100M in Series A+ funding to help end plastic waste', that it raised roughly US$65 million to accelerate the deployment of its enzymatic recycling capabilities and build new facilities in Southeast Asia.
Concurrently, the market is moving toward non-food biomass and waste-based feedstocks, thereby decoupling chemical production from the food supply chain. Manufacturers are increasingly using agricultural residues and industrial off-gases as primary inputs, which lowers carbon footprints and avoids the volatility of commodity crop prices. This transition is enabled by gas fermentation technologies that transform carbon emissions into valuable intermediates like sustainable fuels and ethanol. Illustrating the growing economic viability of these waste-to-value pathways, LanzaTech reported in its August 2024 'Second-Quarter 2024 Financial Results' a 35% year-over-year revenue increase to $17.4 million, driven largely by the expansion of its carbon recycling and biorefining operations.
Report Scope
In this report, the Global White Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global White Biotechnology Market.
Global White Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: